Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | 1500MG mesalazine pellets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 2 | 250MG mesalazine pellets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 3 | 500MG mesalazine pellets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 4 | 750MG mesalazine pellets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 5 | Azathioprine or mesalazine (D00377) | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,Azathioprine sodium 💬 | - | - | [1] 96 96 💬
|
| 6 | Control group: mesalazine enema treatment (D00377) | - | - | - | - | [1] 97 97 💬
|
| 7 | Delayed and extended release mesalazine (D00377) | - | - | - | - | [1] 97 97 💬
|
| 8 | Mesalazine (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [3] 46 46, 96, 97 💬
|
| 9 | Mesalazine - TID 1000 MG (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 10 | Mesalazine - TID 2X 500 MG (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 11 | Mesalazine 1000 MG gastro-resistant tablets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 12 | Mesalazine 250MG tablet and nitazoxanide 500MG oral tablet (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 13 | Mesalazine 4G enema (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 14 | Mesalazine 500 MG gastro-resistant tablets (salofa (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 15 | Mesalazine EC 500 MG (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 96 96 💬
|
| 16 | Mesalazine enema (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 17 | Mesalazine liquid enema (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 18 | Mesalazine SLOW-release granules (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 19 | Mesalazine suppository treatment (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 20 | Mesalazine sustained-release tablets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 96 96 💬
|
| 21 | Mesalazine tablets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 96 96 💬
|
| 22 | Mesalazine with hydrocortisone sodium succinate (D00377) | [2] Hydrocortisone Hydrocortisone,Mesalazine | [2] Hydrocortisone
Hydrocortisone
,Mesalamine (D00377) 💬 | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 23 | Mesalazine, tripterygium glycosides (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 96 96 💬
|
| 24 | MMX mesalamine/ mesalazine (D00377) | - | - | - | - | [1] 97 97 💬
|
| 25 | MMX mesalamine/mesalazine (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 26 | Overencapsulated mesalazine tablets (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|
| 27 | SPD476 IS A polymeric matrix formulation that displays both delayed- and extended-release OF mesalazine (D00377) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
(D00377) 💬
| - | - | [1] 97 97 💬
|